Table 1. Baseline Demographic Variables of the 10 Cases With UC Refractory to Medications Including TAC Who Were Selected for This Combination Therapy With ADA Plus Intensive GMA.
| Demographic | Number of patients |
|---|---|
| Male/female | 6/4 |
| Age (range) | 57.1 (34 - 85) |
| Mean disease duration, years (range) | 8.3 (0.2 - 20) |
| Disease location (n, %) | |
| Extensive | 8 (80) |
| Left-sided | 2 (20) |
| Concurrent medication (n, %) | |
| 5-ASA | 10 (100) |
| Corticosteroids | 10 (100) |
| TAC | 2 (20) |
| Baseline full Mayo scores (mean) | 9.3 |
| Median CRP levels (range) | 1.28 (0.03 - 27.9) |
| Doses of corticosteroids, mg/day (mean) | 26.5 |
| Corticosteroid-dependent/refractory (n, %) | |
| Dependent | 7 (70) |
| Refractory | 3 (30) |
The data are presented as means or median values.